107 related articles for article (PubMed ID: 9043551)
1. FDA announces plan to halt marketing of terfenadine.
Am J Health Syst Pharm; 1997 Feb; 54(4):342. PubMed ID: 9043551
[No Abstract] [Full Text] [Related]
2. Seldane approval may be withdrawn by FDA.
AIDS Patient Care STDS; 1997 Jun; 11(3):197-8. PubMed ID: 11361802
[No Abstract] [Full Text] [Related]
3. Seldane warnings.
Vazquez E; Whitfield L
Posit Aware; 1997; 8(6):12. PubMed ID: 11364851
[TBL] [Abstract][Full Text] [Related]
4. Is my antihistamine safe?
Ashworth L
Home Care Provid; 1997 Jun; 2(3):117-20. PubMed ID: 9274181
[TBL] [Abstract][Full Text] [Related]
5. Terfenadine overdose induced polymorphous ventricular tachycardia.
Kothari SS; Sharma S; Wasir HS
Indian Pediatr; 1995 Oct; 32(10):1107-08. PubMed ID: 8984050
[No Abstract] [Full Text] [Related]
6. QT lengthening and life-threatening arrhythmias associated with fexofenadine.
Pinto YM; van Gelder IC; Heeringa M; Crijns HJ
Lancet; 1999 Mar; 353(9157):980. PubMed ID: 10459910
[No Abstract] [Full Text] [Related]
7. Drug interactions associated with terfenadine and related nonsedating antihistamines.
Zechnich AD; Haxby DG
West J Med; 1996 Jan; 164(1):68-9. PubMed ID: 8779212
[No Abstract] [Full Text] [Related]
8. Terfenadine should be withdrawn from clinical use.
Khilnani G
J Assoc Physicians India; 1999 Sep; 47(9):943. PubMed ID: 10778682
[No Abstract] [Full Text] [Related]
9. From the Food and Drug Administration.
Nightingale SL
JAMA; 1997 Feb; 277(5):370. PubMed ID: 9010159
[No Abstract] [Full Text] [Related]
10. Terfenadine and SSRIs.
Tafler G
CMAJ; 1997 Oct; 157(8):1019. PubMed ID: 9347771
[No Abstract] [Full Text] [Related]
11. Terfenadine therapy: can we justify the risks?
Rangno R
CMAJ; 1997 Jul; 157(1):37-8. PubMed ID: 9220940
[No Abstract] [Full Text] [Related]
12. Use of terfenadine and contraindicated drugs.
Zechnich AD; Hedges JR
JAMA; 1996 Sep; 276(12):953. PubMed ID: 8805725
[No Abstract] [Full Text] [Related]
13. Drug interactions, cardiac toxicity, and terfenadine: from bench to clinic?
Flockhart DA
J Clin Psychopharmacol; 1996 Apr; 16(2):101-3. PubMed ID: 8690824
[No Abstract] [Full Text] [Related]
14. Second-generation antihistamines: the risk of ventricular arrhythmias.
DuBuske LM
Clin Ther; 1999 Feb; 21(2):281-95. PubMed ID: 10211532
[TBL] [Abstract][Full Text] [Related]
15. Erythromycin and ketoconazole (Nizoral) associated with terfenadine (Seldane)-induced ventricular arrhythmias.
Wynn RL
Gen Dent; 1993; 41(1):27-9. PubMed ID: 7489857
[No Abstract] [Full Text] [Related]
16. Lack of association between fexofenadine and rhabdomyolysis.
Adesanya H
Am J Health Syst Pharm; 2004 Apr; 61(7):724-5; author reply 725. PubMed ID: 15119580
[No Abstract] [Full Text] [Related]
17. Non-sedating antihistamines and cardiac arrhythmia.
Rankin AC
Lancet; 1997 Oct; 350(9085):1115-6. PubMed ID: 9343494
[No Abstract] [Full Text] [Related]
18. [Drug side effects and their prevention].
Hautarzt; 1997 Aug; 48(8 Suppl):3-4. PubMed ID: 9378645
[No Abstract] [Full Text] [Related]
19. Terfenadine-induced cholestatic hepatitis.
Sahai A; Villeneuve JP
Lancet; 1996 Aug; 348(9026):552-3. PubMed ID: 8757175
[No Abstract] [Full Text] [Related]
20. Cardiac actions of antihistamines.
Woosley RL
Annu Rev Pharmacol Toxicol; 1996; 36():233-52. PubMed ID: 8725389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
